Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP547455.RARKuM0M5wbFMWToM0lj0rxQ_rJy1lAKzBt9P0V-AbMlI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP547455.RARKuM0M5wbFMWToM0lj0rxQ_rJy1lAKzBt9P0V-AbMlI130_assertion type Assertion NP547455.RARKuM0M5wbFMWToM0lj0rxQ_rJy1lAKzBt9P0V-AbMlI130_head.
- NP547455.RARKuM0M5wbFMWToM0lj0rxQ_rJy1lAKzBt9P0V-AbMlI130_assertion description "[SEL1L immunoreactivity can be detected both in the cytoplasm and less commonly in the nuclei; the subcellular location correlates with tumor histotype, with cytoplasmic immunoreactivity being most prevalent in squamous cell carcinomas (P = .0005) and nuclear immunoreactivity being associated with adenocarcinomas (P = .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547455.RARKuM0M5wbFMWToM0lj0rxQ_rJy1lAKzBt9P0V-AbMlI130_provenance.
- NP547455.RARKuM0M5wbFMWToM0lj0rxQ_rJy1lAKzBt9P0V-AbMlI130_assertion evidence source_evidence_literature NP547455.RARKuM0M5wbFMWToM0lj0rxQ_rJy1lAKzBt9P0V-AbMlI130_provenance.
- NP547455.RARKuM0M5wbFMWToM0lj0rxQ_rJy1lAKzBt9P0V-AbMlI130_assertion SIO_000772 16647946 NP547455.RARKuM0M5wbFMWToM0lj0rxQ_rJy1lAKzBt9P0V-AbMlI130_provenance.
- NP547455.RARKuM0M5wbFMWToM0lj0rxQ_rJy1lAKzBt9P0V-AbMlI130_assertion wasDerivedFrom befree-2016 NP547455.RARKuM0M5wbFMWToM0lj0rxQ_rJy1lAKzBt9P0V-AbMlI130_provenance.
- NP547455.RARKuM0M5wbFMWToM0lj0rxQ_rJy1lAKzBt9P0V-AbMlI130_assertion wasGeneratedBy ECO_0000203 NP547455.RARKuM0M5wbFMWToM0lj0rxQ_rJy1lAKzBt9P0V-AbMlI130_provenance.